Back to Search Start Over

Intraductal papillary neoplasms of the bile duct: a European retrospective multicenter observational study (EUR-IPNB study)

Authors :
Núria Lluís
Mario Serradilla-Martín
Mar Achalandabaso
François Jehaes
Bobby V.M. Dasari
Sara Mambrilla-Herrero
Ernesto Sparrelid
Anita Balakrishnan
Frederik J.H. Hoogwater
Maria J. Amaral
Bodil Andersson
Frederik Berrevoet
Alexandre Doussot
Víctor López-López
Mohammedsuror Alsammani
Olivier Detry
Carlos Domingo-del Pozo
Nikolaos Machairas
Damján Pekli
Cándido F. Alcázar-López
Horacio Asbun
Bergthor Björnsson
Thalis Christophides
Alberto Díez-Caballero
David Francart
Colin B. Noel
Donzília Sousa-Silva
Enrique Toledo-Martínez
George N. Tzimas
Sheraz Yaqub
François Cauchy
Mikel Prieto-Calvo
Melroy A. D’Souza
Harry V.M. Spiers
Marius C. van den Heuvel
Ramón Charco
Mickaël Lesurtel
José M. Ramia
Source :
International Journal of Surgery. 109:760-771
Publication Year :
2023
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2023.

Abstract

BACKGROUND/PURPOSE: Intraductal papillary neoplasm of the bile duct (IPNB) is a rare disease in Western countries. The main aim of this study was to characterize current surgical strategies and outcomes in the mainly European participating centers.METHODS: A multi-institutional retrospective series of patients with a diagnosis of IPNB undergoing surgery between 1 January 2010 and 31 December 2020 was gathered under the auspices of the European-African Hepato-Pancreato-Biliary Association. The textbook outcome (TO) was defined as a non-prolonged length of hospital stay plus the absence of any Clavien-Dindo grade at least III complications, readmission, or mortality within 90 postoperative days.RESULTS: A total of 28 centers contributed 85 patients who underwent surgery for IPNB. The median age was 66 years (55-72), 49.4% were women, and 87.1% were Caucasian. Open surgery was performed in 72 patients (84.7%) and laparoscopic in 13 (15.3%). TO was achieved in 54.1% of patients, reaching 63.8% after liver resection and 32.0% after pancreas resection. Median overall survival was 5.72 years, with 5-year overall survival of 63% (95% CI: 50-82). Overall survival was better in patients with Charlson comorbidity score 4 or less versus more than 4 ( P =0.016), intrahepatic versus extrahepatic tumor ( P =0.027), single versus multiple tumors ( P =0.007), those who underwent hepatic versus pancreatic resection ( P =0.017), or achieved versus failed TO ( P =0.029). Multivariable Cox regression analysis showed that not achieving TO (HR: 4.20; 95% CI: 1.11-15.94; P =0.03) was an independent prognostic factor of poor overall survival.CONCLUSIONS: Patients undergoing liver resection for IPNB were more likely to achieve a TO outcome than those requiring a pancreatic resection. Comorbidity, tumor location, and tumor multiplicity influenced overall survival. TO was an independent prognostic factor of overall survival.

Subjects

Subjects :
Surgery
General Medicine

Details

ISSN :
17439191
Volume :
109
Database :
OpenAIRE
Journal :
International Journal of Surgery
Accession number :
edsair.doi.dedup.....099dc7226004f7c67a136389e5432974
Full Text :
https://doi.org/10.1097/js9.0000000000000280